PMID- 4040369
OWN - NLM
STAT- MEDLINE
DCOM- 19850815
LR  - 20190623
IS  - 0006-2952 (Print)
IS  - 0006-2952 (Linking)
VI  - 34
IP  - 14
DP  - 1985 Jul 15
TI  - Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in 
      drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine 
      sulfoximine mediated glutathione depletion.
PG  - 2583-6
FAU - Hamilton, T C
AU  - Hamilton TC
FAU - Winker, M A
AU  - Winker MA
FAU - Louie, K G
AU  - Louie KG
FAU - Batist, G
AU  - Batist G
FAU - Behrens, B C
AU  - Behrens BC
FAU - Tsuruo, T
AU  - Tsuruo T
FAU - Grotzinger, K R
AU  - Grotzinger KR
FAU - McKoy, W M
AU  - McKoy WM
FAU - Young, R C
AU  - Young RC
FAU - Ozols, R F
AU  - Ozols RF
LA  - eng
PT  - Journal Article
PL  - England
TA  - Biochem Pharmacol
JT  - Biochemical pharmacology
JID - 0101032
RN  - 1982-67-8 (Methionine Sulfoximine)
RN  - 5072-26-4 (Buthionine Sulfoximine)
RN  - 80168379AG (Doxorubicin)
RN  - GAN16C9B8O (Glutathione)
RN  - Q20Q21Q62J (Cisplatin)
RN  - Q41OR9510P (Melphalan)
SB  - IM
MH  - Buthionine Sulfoximine
MH  - Cell Line
MH  - Cell Survival/drug effects
MH  - Cisplatin/*pharmacology
MH  - Doxorubicin/metabolism/*pharmacology
MH  - Drug Resistance
MH  - Drug Synergism
MH  - Female
MH  - Glutathione/*metabolism
MH  - Humans
MH  - Melphalan/metabolism/*pharmacology
MH  - Methionine Sulfoximine/*analogs & derivatives/pharmacology
MH  - Ovarian Neoplasms/*drug therapy/pathology
EDAT- 1985/07/15 00:00
MHDA- 1985/07/15 00:01
CRDT- 1985/07/15 00:00
PHST- 1985/07/15 00:00 [pubmed]
PHST- 1985/07/15 00:01 [medline]
PHST- 1985/07/15 00:00 [entrez]
AID - 0006-2952(85)90551-9 [pii]
AID - 10.1016/0006-2952(85)90551-9 [doi]
PST - ppublish
SO  - Biochem Pharmacol. 1985 Jul 15;34(14):2583-6. doi: 10.1016/0006-2952(85)90551-9.